Jack A. Khattar - Dec 3, 2021 Form 4 Insider Report for scPharmaceuticals Inc. (SCPH)

Role
Director
Signature
/s/ John H. Tucker, Attorney in Fact
Stock symbol
SCPH
Transactions as of
Dec 3, 2021
Transactions value $
$19,569
Form type
4
Date filed
12/6/2021, 04:55 PM
Previous filing
Oct 7, 2021
Next filing
Feb 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCPH Common Stock Purchase $19.6K +5K $3.91 5K Dec 3, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.90 to $3.923, inclusive. The reporting person undertakes to provide to scPharmaceuticals Inc., any security holder of scPharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (1) to this Form 4